Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arteris (AIP) Cash & Equivalents (2023 - 2025)

Arteris (AIP) has disclosed Cash & Equivalents for 3 consecutive years, with $17.4 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash & Equivalents fell 2.31% year-over-year to $17.4 million, compared with a TTM value of $17.4 million through Sep 2025, down 2.31%, and an annual FY2024 reading of $13.7 million, changed 0.09% over the prior year.
  • Cash & Equivalents was $17.4 million for Q3 2025 at Arteris, up from $16.1 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $28.5 million in Q1 2023 and bottomed at $13.7 million in Q4 2024.
  • Average Cash & Equivalents over 3 years is $20.0 million, with a median of $18.2 million recorded in 2023.
  • The sharpest move saw Cash & Equivalents dropped 0.09% in 2024, then dropped 27.24% in 2025.
  • Year by year, Cash & Equivalents stood at $13.7 million in 2023, then decreased by 0.09% to $13.7 million in 2024, then grew by 27.28% to $17.4 million in 2025.
  • Business Quant data shows Cash & Equivalents for AIP at $17.4 million in Q3 2025, $16.1 million in Q2 2025, and $13.7 million in Q4 2024.